Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection (coronavirus illness 2019; COVID-19) is related with hostile outcomes in sufferers with heart problems (CVD). The purpose of the examine was to characterize the interplay between SARS-CoV-2 and Angiotensin-Converting Enzyme 2 (ACE2) purposeful networks with a concentrate on CVD. Using the community drugs strategy and publicly obtainable datasets, we investigated ACE2 tissue expression and described ACE2 interplay networks that could possibly be affected by SARS-CoV-2 an infection in the center, lungs and nervous system.
We in contrast them with modifications in ACE-2 networks following SARS-CoV-2 an infection by analyzing public information of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). This evaluation was carried out utilizing the Network by Relative Importance (NERI) algorithm, which integrates protein-protein interplay with co-expression networks. We additionally carried out miRNA-target predictions to establish which miRNAs regulate ACE2-related networks and will play a job in the COVID19 final result. Finally, we carried out enrichment evaluation for figuring out the primary COVID-19 threat teams.
We discovered related ACE2 expression confidence ranges in respiratory and cardiovascular methods, supporting that coronary heart tissue is a possible goal of SARS-CoV-2. Analysis of ACE2 interplay networks in contaminated hiPSC-CMs recognized a number of hub genes with corrupted signaling which could be accountable for cardiovascular signs. The most affected genes had been EGFR (Epidermal Growth Factor Receptor), FN1 (Fibronectin 1), TP53, HSP90AA1, and APP (Amyloid Beta Precursor Protein), whereas probably the most affected interactions had been related with MAST2 and CALM1 (Calmodulin 1).
Enrichment evaluation revealed a number of ailments related with the interplay networks of ACE2, particularly cancerous ailments, weight problems, hypertensive illness, Alzheimer’s illness, non-insulin-dependent diabetes mellitus, and congestive coronary heart failure. Among affected ACE2-network elements related with the SARS-Cov-2 interactome, we recognized AGT (Angiotensinogen), CAT (Catalase), DPP4 (Dipeptidyl Peptidase 4), CCL2 (C-C Motif Chemokine Ligand 2), TFRC (Transferrin Receptor) and CAV1 (Caveolin-1), related with cardiovascular threat elements.
We described for the primary time miRNAs which had been widespread regulators of ACE2 networks and virus-related proteins in all analyzed datasets. The high miRNAs regulating ACE2 networks had been miR-27a-3p, miR-26b-5p, miR-10b-5p, miR-302c-5p, hsa-miR-587, hsa-miR-1305, hsa-miR-200b-3p, hsa-miR-124-3p, and hsa-miR-16-5p. Our examine gives an entire mechanistic framework for investigating the ACE2 community which was validated by expression information. This framework predicted threat teams, together with the established ones, thus offering dependable novel info concerning the complexity of signaling pathways affected by SARS-CoV-2. It additionally recognized miRNAs that could possibly be used in personalised prognosis in COVID-19.
Treatment of keloids by Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway
Keloids are a pores and skin fibroproliferative situation characterised by the hyperproliferation of fibroblasts and the extreme deposition of extracellular matrix (ECM) elements. Previous research have decided that Caveolin‑1 managed hyperresponsiveness to mechanical stimuli by Runt‑associated transcription issue 2 (Runx2) activation in keloids. However, the molecular mechanism of Runx2 regulating the pathological development of keloids has not been elucidated. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) evaluation revealed that the majority of the differentially expressed genes (DEGs), together with Runx2, had been considerably enriched in the organic processes
Positive regulation of cell proliferation’, in the mobile elements ‘Extracellular matrix’, in the molecular features ‘Extracellular matrix structural constituents’ and in the KEGG ‘PI3K‑Akt signaling pathway’. The purpose of the current examine was to research the expression ranges of the Runx2 in human keloid tissues and first human keloid fibroblasts (HKFs), and to find out the underlying molecular mechanisms concerned in the fibrotic roles of Runx2 in keloid formation. Runx2 expression ranges had been analyzed in affected person keloid tissues and HKFs utilizing western blotting, reverse transcription‑quantitative PCR (RT‑qPCR) and immunofluorescence microscopy.
Primary HKFs had been transfected with a small interfering RNA (si) particularly concentrating on Runx2 (si‑Runx2). Subsequently, Cell Counting Kit‑8, wound therapeutic and Transwell assays, movement cytometry, RT‑qPCR and western blotting had been utilized to judge the proliferation, migration, apoptosis, ECM deposition and PI3K/AKT signaling pathway of HKFs, respectively. In addition, western blotting was additionally used to find out the expression ranges of phosphorylated AKT and PI3K in HKFs. The outcomes revealed that Runx2 expression ranges had been upregulated in keloid tissues and first HKFs in contrast with the conventional pores and skin tissues and human regular fibroblasts.
Following the transfection with si‑Runx2, the proliferative and migratory skills of HKFs had been considerably lowered and the apoptotic charge was elevated. The expression ranges of kind I, kind III collagen, fibronectin, and α‑easy muscle actin had been downregulated in si‑Runx2‑transfected cells, which was hypothesized to happen by following the downregulation of the phosphorylation ranges of PI3K and AKT. In conclusion, the findings of the current examine indicated that Runx2 silencing in HKFs may considerably inhibit the cell proliferation, migration and the expression ranges of ECM‑associated proteins, and promote apoptosis by way of suppressing the PI3K/AKT signaling pathway.
 Anti-CAV1 antibody |
|
STJ22912 |
St John's Laboratory |
100 µl |
EUR 277 |
|
Description: The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1. |
Anti-CAV1 antibody |
|
STJ140019 |
St John's Laboratory |
100 µg |
EUR 231 |
|
Description: Goat polyclonal to Caveolin- 1 – caveolae marker. This scaffolding protein is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras- ERK pathway and promoting cell cycle progression. |
 CAV1 Polyclonal Antibody |
|
ABP-PAB-31007 |
Allele Biotech |
50 ug |
Ask for price |
|
|
CAV1 Polyclonal Antibody |
|
ABP-PAB-31008 |
Allele Biotech |
50 ug |
Ask for price |
|
|
CAV1 Polyclonal Antibody |
|
ABP-PAB-31009 |
Allele Biotech |
50 ug |
Ask for price |
|
|
 CAV1 Antibody |
|
1-CSB-PA001332 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
CAV1 Antibody |
|
1-CSB-PA001333 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/5000 |
CAV1 Antibody |
|
1-CSB-PA004571GA01HU |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
CAV1 Antibody |
|
1-CSB-PA004571OA01HU |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200 |
CAV1 Antibody |
|
1-CSB-PA035530 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:10000, WB:1:1000-1:5000, IHC:1:50-1:200 |
CAV1 Antibody |
|
CSB-PA870052- |
Cusabio |
|
EUR 335 |
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500 |
CAV1 Antibody |
|
CSB-PA870052-100ul |
Cusabio |
100ul |
EUR 316 |
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:3000, IF:1:100-1:500 |
CAV1 Antibody |
|
1-CSB-PA136745 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CAV1. Recognizes CAV1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
CAV1 Antibody |
|
37401-100ul |
SAB |
100ul |
EUR 252 |
 CAV1 antibody |
|
20R-CR070 |
Fitzgerald |
50 ug |
EUR 656 |
|
Description: Rabbit polyclonal CAV1 antibody |
CAV1 antibody |
|
20R-CR071 |
Fitzgerald |
50 ug |
EUR 656 |
|
Description: Rabbit polyclonal CAV1 antibody |
CAV1 antibody |
|
20R-CR072 |
Fitzgerald |
50 ug |
EUR 656 |
|
Description: Rabbit polyclonal CAV1 antibody |
CAV1 antibody |
|
20R-1315 |
Fitzgerald |
100 ug |
EUR 377 |
|
Description: Rabbit polyclonal CAV1 antibody |
CAV1 antibody |
|
70R-16188 |
Fitzgerald |
50 ul |
EUR 435 |
|
Description: Rabbit polyclonal CAV1 antibody |
CAV1 antibody |
|
70R-2555 |
Fitzgerald |
50 ug |
EUR 467 |
|
Description: Rabbit polyclonal CAV1 antibody raised against the N terminal of CAV1 |
CAV1 antibody |
|
70R-14053 |
Fitzgerald |
100 ug |
EUR 322 |
|
Description: Affinity purified Rabbit polyclonal CAV1 antibody |
CAV1 antibody |
|
70R-51478 |
Fitzgerald |
100 ul |
EUR 287 |
|
Description: Purified Polyclonal CAV1 antibody |
CAV1 antibody |
|
70R-37551 |
Fitzgerald |
100 ug |
EUR 273 |
|
Description: Rabbit Polyclonal CAV1 antibody |
CAV1 antibody |
|
70R-CR002 |
Fitzgerald |
100 ug |
EUR 673 |
|
Description: Affinity purified Rabbit polyclonal CAV1 antibody |
 Anti-Caveolin-1/CAV1 Antibody |
|
PA1514 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-Caveolin-1/CAV1 Antibody |
|
PB9165 |
BosterBio |
100ug/vial |
EUR 334 |
 antibody) Anti-Phospho-CAV1-(Y14) antibody |
|
STJ22049 |
St John's Laboratory |
100 µl |
EUR 393 |
|
Description: The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1. |
Anti-Phospho-CAV1-(Y14) antibody |
|
STJ116375 |
St John's Laboratory |
100 µl |
EUR 393 |
|
Description: The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1. |
 Rabbit Anti-Human CAV1 Polyclonal Antibody, Phospho-Tyr14 |
|
CPB-654RH |
Creative Diagnostics |
100 ul |
EUR 559 |
 ELISA Kit) Bovine Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 555 |
Bovine Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 771 |
 ELISA Kit) Canine Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 533 |
Canine Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 740 |
 ELISA Kit) Chicken Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Ch-48Tests |
Reddot Biotech |
48 Tests |
EUR 511 |
Chicken Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Ch-96Tests |
Reddot Biotech |
96 Tests |
EUR 709 |
 ELISA Kit) Goat Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-g-48Tests |
Reddot Biotech |
48 Tests |
EUR 566 |
Goat Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-g-96Tests |
Reddot Biotech |
96 Tests |
EUR 787 |
 ELISA Kit) Human Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 478 |
Human Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 662 |
 ELISA Kit) Mouse Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 489 |
Mouse Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 677 |
 ELISA Kit) Porcine Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 555 |
Porcine Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 771 |
 ELISA Kit) Rat Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 511 |
Rat Caveolin 1 (CAV1) ELISA Kit |
|
RD-CAV1-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 709 |
Bovine Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-b-48T |
DL Develop |
48T |
EUR 547 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-b-96T |
DL Develop |
96T |
EUR 715 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Canine Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-c-48T |
DL Develop |
48T |
EUR 527 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Canine Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Canine Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-c-96T |
DL Develop |
96T |
EUR 688 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Canine Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Chicken Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Ch-48T |
DL Develop |
48T |
EUR 508 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Chicken Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
Chicken Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Ch-96T |
DL Develop |
96T |
EUR 661 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Chicken Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates, cell lysates or other biological fluids. |
Goat Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-g-48T |
DL Develop |
48T |
EUR 556 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Goat Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Goat Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-g-96T |
DL Develop |
96T |
EUR 728 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Goat Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Hu-48T |
DL Develop |
48T |
EUR 479 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Caveolin 1 (CAV1) in samples from tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Hu-96T |
DL Develop |
96T |
EUR 621 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Caveolin 1 (CAV1) in samples from tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Mu-48T |
DL Develop |
48T |
EUR 489 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Mouse Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Mu-96T |
DL Develop |
96T |
EUR 635 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Porcine Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-p-48T |
DL Develop |
48T |
EUR 547 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-p-96T |
DL Develop |
96T |
EUR 715 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Caveolin 1 (CAV1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Ra-48T |
DL Develop |
48T |
EUR 508 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Caveolin 1 (CAV1) in samples from serum, plasma or other biological fluids. |
Rat Caveolin 1 (CAV1) ELISA Kit |
|
DLR-CAV1-Ra-96T |
DL Develop |
96T |
EUR 661 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Caveolin 1 (CAV1) in samples from serum, plasma or other biological fluids. |
Bovine Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 580 |
Bovine Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 807 |
Canine Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 557 |
Canine Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 774 |
Chicken Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Ch-48Tests |
Reddot Biotech |
48 Tests |
EUR 534 |
Chicken Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Ch-96Tests |
Reddot Biotech |
96 Tests |
EUR 742 |
Goat Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-g-48Tests |
Reddot Biotech |
48 Tests |
EUR 591 |
Goat Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-g-96Tests |
Reddot Biotech |
96 Tests |
EUR 823 |
Human Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 500 |
Human Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 692 |
Mouse Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 511 |
Mouse Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 709 |
Porcine Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 580 |
Porcine Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 807 |
Rat Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 534 |
Rat Caveolin 1 (CAV1) ELISA Kit |
|
RDR-CAV1-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 742 |
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 10 (MLLT10) polyclonal antibody |
|
ABP-PAB-10850 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 1 (MLLT1) polyclonal antibody |
|
ABP-PAB-10851 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 2 (MLLT2) polyclonal antibody |
|
ABP-PAB-10852 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 3 (MLLT3) polyclonal antibody |
|
ABP-PAB-10853 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 4 (MLLT4) polyclonal antibody |
|
ABP-PAB-10854 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 6 (MLLT6) polyclonal antibody |
|
ABP-PAB-10855 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 polyclonal antibody) Myeloid/lymphoid or mixed-lineage leukemia translocated to 7 (MLLT7) polyclonal antibody |
|
ABP-PAB-10856 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 Polyclonal Goat anti-GST α-form |
|
GST-ANTI-1 |
Detroit R&D |
50 uL |
EUR 280 |
 Polyclonal Goat anti-GST μ-form |
|
GST-ANTI-2 |
Detroit R&D |
50 uL |
EUR 280 |
 Polyclonal Goat anti-GST p-form |
|
GST-ANTI-3 |
Detroit R&D |
50 uL |
EUR 280 |
 Polyclonal Antibody) Rabbit Anti-Human CAV1 (aa 12-16) Polyclonal Antibody |
|
CPB-1020RH |
Creative Diagnostics |
100 ul |
EUR 460 |
 OR Antibody |
|
20-abx217389 |
Abbexa |
|
|
|
|
OR Antibody |
|
44609-100ul |
SAB |
100ul |
EUR 252 |
OR Antibody |
|
44609-50ul |
SAB |
50ul |
EUR 187 |
OR Antibody |
|
DF10250 |
Affbiotech |
200ul |
EUR 304 |
|
Description: OR Antibody detects endogenous levels of total OR. |
 Polyclonal Antibody (Mouse)) Caveolin 1 (CAV1) Polyclonal Antibody (Mouse) |
|
4-PAA214Mu01 |
Cloud-Clone |
-
EUR 236.00
-
EUR 2338.00
-
EUR 586.00
-
EUR 294.00
-
EUR 209.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Caveolin 1 (CAV1) |
) Polyclonal CAV1 / Caveolin 1 Antibody (Internal) |
|
APG02439G |
Leading Biology |
0.05mg |
EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human CAV1 / Caveolin 1 (Internal). This antibody is tested and proven to work in the following applications: |
 Antibody) CAV1 (pY14) Antibody |
|
20-abx000368 |
Abbexa |
-
EUR 495.00
-
EUR 704.00
-
EUR 356.00
|
|
|
|
This paper aimed to discover the genome-wide DNA methylation standing of methamphetamine (MA) abusers with completely different qualities to habit and to establish differentially methylated candidate genes. A complete of 207 male MA abusers with an MA abuse frequency of ≥10 instances and an MA abuse length of ≥1 12 months had been assigned to the excessive MA habit high quality group (HMAQ group; 168 topics who met the diagnostic standards for MA dependence in response to the DSM-IV) or to the low MA addictive high quality group (LMAQ group; 39 topics who didn’t meet the factors for MA dependence). In addition 105 wholesome controls had been recruited.
